These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8821577)

  • 21. Interleukin-12: a pivotal regulator of cell-mediated immunity.
    Gately MK; Brunda MJ
    Cancer Treat Res; 1995; 80():341-66. PubMed ID: 8821585
    [No Abstract]   [Full Text] [Related]  

  • 22. Interleukin-4 and its receptor: essential mediators of the allergic response.
    Ryan JJ
    J Allergy Clin Immunol; 1997 Jan; 99(1 Pt 1):1-5. PubMed ID: 9003204
    [No Abstract]   [Full Text] [Related]  

  • 23. Biology of natural and recombinant soluble interleukin-4 receptor.
    Enssle K; Enders B; Kurrle R; Lauffer L; Schorlemmer HU; Dickneite G; Kanzy EJ; Seiler FR
    Behring Inst Mitt; 1995 Jun; (96):103-17. PubMed ID: 7575346
    [No Abstract]   [Full Text] [Related]  

  • 24. Functions of IL-4 and control of its expression.
    Brown MA; Hural J
    Crit Rev Immunol; 1997; 17(1):1-32. PubMed ID: 9034722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor and antimetastatic activity of interleukin-12.
    Hendrzak JA; Brunda MJ
    Curr Top Microbiol Immunol; 1996; 213 ( Pt 3)():65-83. PubMed ID: 8815011
    [No Abstract]   [Full Text] [Related]  

  • 26. Structure/function analysis of interleukin 4: interspecies comparison and site-directed mutagenesis.
    Chapman CG; Clinkenbeard HE; Parker KE; Spackman VM; Dobbelaere DA; Robinson JH; Browne MJ
    Biochem Soc Trans; 1994 May; 22(2):234S. PubMed ID: 7958295
    [No Abstract]   [Full Text] [Related]  

  • 27. Current concepts of B cell modulation.
    Matsuda T; Yamasaki K; Taga T; Hirano T; Kishimoto T
    Int Rev Immunol; 1989; 5(2):97-109. PubMed ID: 8691054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Membrane-bound and soluble interleukin-6 receptor: studies on structure, regulation of expression, and signal transduction.
    Heinrich PC; Graeve L; Rose-John S; Schneider-Mergener J; Dittrich E; Erren A; Gerhartz C; Hemann U; Lütticken C; Wegenka U
    Ann N Y Acad Sci; 1995 Jul; 762():222-36; discussion 236-7. PubMed ID: 7545364
    [No Abstract]   [Full Text] [Related]  

  • 29. Structure, binding, and antagonists in the IL-4/IL-13 receptor system.
    Mueller TD; Zhang JL; Sebald W; Duschl A
    Biochim Biophys Acta; 2002 Nov; 1592(3):237-50. PubMed ID: 12421669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-13 (IL-13) pathway.
    Kelly-Welch A; Hanson EM; Keegan AD
    Sci STKE; 2005 Jul; 2005(293):cm8. PubMed ID: 16030286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor.
    Hilton DJ; Zhang JG; Metcalf D; Alexander WS; Nicola NA; Willson TA
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):497-501. PubMed ID: 8552669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct mechanisms for rescue from apoptosis in Ramos human B cells by signalling through CD40 and interleukin-4 receptor: role for inhibition of an early response gene, Berg36.
    Ning ZQ; Norton JD; Li J; Murphy JJ
    Biochem Soc Trans; 1997 May; 25(2):306S. PubMed ID: 9191350
    [No Abstract]   [Full Text] [Related]  

  • 33. Homodimerization of interleukin-4 receptor alpha chain can induce intracellular signaling.
    Kammer W; Lischke A; Moriggl R; Groner B; Ziemiecki A; Gurniak CB; Berg LJ; Friedrich K
    J Biol Chem; 1996 Sep; 271(39):23634-7. PubMed ID: 8798580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-10 (IL-10).
    Benjamin D
    Cancer Treat Res; 1995; 80():305-19. PubMed ID: 8821583
    [No Abstract]   [Full Text] [Related]  

  • 35. IL-4 induces human B cell maturation and IgE synthesis in SCID-hu mice. Inhibition of ongoing IgE production by in vivo treatment with an IL-4/IL-13 receptor antagonist.
    Carballido JM; Schols D; Namikawa R; Zurawski S; Zurawski G; Roncarolo MG; de Vries JE
    J Immunol; 1995 Nov; 155(9):4162-70. PubMed ID: 7594571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cytokine binding proteins: a model of interleukin 6].
    Brailly H; Montero-Julian FA
    Arch Inst Pasteur Tunis; 1994; 71(3-4):535-48. PubMed ID: 8801856
    [No Abstract]   [Full Text] [Related]  

  • 37. An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors.
    Aversa G; Punnonen J; Cocks BG; de Waal Malefyt R; Vega F; Zurawski SM; Zurawski G; de Vries JE
    J Exp Med; 1993 Dec; 178(6):2213-8. PubMed ID: 7504061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-4 induces germ-line IgE heavy chain gene transcription in human fetal pre-B cells. Evidence for differential expression of functional IL-4 and IL-13 receptors during B cell ontogeny.
    Punnonen J; Cocks BG; de Vries JE
    J Immunol; 1995 Nov; 155(9):4248-54. PubMed ID: 7594582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin 4: signalling mechanisms and control of T cell differentiation.
    Paul WE
    Ciba Found Symp; 1997; 204():208-16; discussion 216-9. PubMed ID: 9107423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin 7 receptor-deficient mice lack gammadelta T cells.
    Maki K; Sunaga S; Komagata Y; Kodaira Y; Mabuchi A; Karasuyama H; Yokomuro K; Miyazaki JI; Ikuta K
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7172-7. PubMed ID: 8692964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.